M
Mark Pimentel
Researcher at Cedars-Sinai Medical Center
Publications - 366
Citations - 12985
Mark Pimentel is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Irritable bowel syndrome & Small intestinal bacterial overgrowth. The author has an hindex of 55, co-authored 327 publications receiving 10861 citations. Previous affiliations of Mark Pimentel include University of Calgary & University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
Mark Pimentel,Anthony Lembo,William D. Chey,Salam Zakko,Yehuda Ringel,Jing Yu,Shadreck M. Mareya,Audrey L. Shaw,Enoch Bortey,William P. Forbes +9 more
TL;DR: Among patients who had IBS without constipation, treatment with rifaximin for 2 weeks provided significant relief of IBS symptoms, bloating, abdominal pain, and loose or watery stools.
Journal ArticleDOI
Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome
TL;DR: An improvement in irritable bowel syndrome symptoms with diarrhea and abdominal pain being statistically significant after Bonferroni correction is revealed.
Journal ArticleDOI
Normalization of Lactulose Breath Testing Correlates With Symptom Improvement in Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Study
TL;DR: Normalization of LBT with neomycin leads to a significant reduction in IBS symptoms, and the type of gas seen on LBT is also associated with IBS subgroup.
Journal ArticleDOI
Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus
Ali Rezaie,Michelle Buresi,Anthony Lembo,Henry C. Lin,Richard W. McCallum,Satish S.C. Rao,Max Schmulson,Miguel A. Valdovinos,Salam Zakko,Mark Pimentel +9 more
TL;DR: BT is a useful, inexpensive, simple and safe diagnostic test in the evaluation of common gastroenterology problems and should help to standardize the indications, preparation, performance and interpretation of BT in clinical practice and research.
Journal ArticleDOI
The Effect of a Nonabsorbed Oral Antibiotic (Rifaximin) on the Symptoms of the Irritable Bowel Syndrome: A Randomized Trial
TL;DR: In this paper, a double-blind, randomized, placebo-controlled study was conducted to determine whether the nonabsorbed antibiotic rifaximin is more effective than placebo in reducing symptoms in adults with IBS.